Literature DB >> 6458258

Development of an infection-resistant vascular prosthesis.

W S Moore, M Chvapil, G Seiffert, K Keown.   

Abstract

To develop an infection-resistant arterial prosthesis, amikacin was bonded to 6-mm, uncrimped, filamentous velour prostheses using a collagen-release system. Infrarenal abdominal aortas were resected in 26 mongrel dogs. Thirteen dogs had their aortas replaced with the antibiotic-bonded grafts and 13 dogs had their aortas replaced with a graft containing collagen without antibiotics. Following closure of the abdominal incision, each dog received an intravenous infusion of 10(8) organisms of Staphylococcus aureus administered over a 30-minute interval. Three weeks after recovery from operation, the grafts were removed under aseptic conditions; all 13 (100%) of the control grafts were infected, but only one of 12 experimental grafts (8%) was infected. There were no adverse healing effects; to the contrary, there appeared to be accelerated development of a cellular neointima and fibroblastic infiltration to the interstices. Antibiotic bonding with a collagen-release system is a promising method for imparting infection resistance to a vascular prosthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458258     DOI: 10.1001/archsurg.1981.01380230027004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

Review 1.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Review: Microbial colonization of prosthetic devices.

Authors:  M Jacques; T J Marrie; J W Costerton
Journal:  Microb Ecol       Date:  1987-05       Impact factor: 4.552

3.  Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials.

Authors:  R Bayston; N Grove; J Siegel; D Lawellin; S Barsham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

4.  Priority of revascularization in patients with graft enteric fistulas, infected arteries, or infected arterial prostheses.

Authors:  H H Trout; L Kozloff; J M Giordano
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

5.  New anti-infective coatings of medical implants.

Authors:  F D Matl; A Obermeier; S Repmann; W Friess; A Stemberger; K-D Kuehn
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.